A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Servier
Pfizer
Eli Lilly and Company
Bristol-Myers Squibb
Revolution Medicines, Inc.
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Artios Pharma Ltd
Genfleet Therapeutics (Shanghai) Inc.
Taiho Pharmaceutical Co., Ltd.
Northwestern University
Oslo University Hospital